Dado Medical s.r.o.
- Address
- Budecska 2165/33, Vinohrady, 120 00 Prague, Czechia
Dado Medical s.r.o. - Specialized Neurological Pain Research Center
Dado Medical s.r.o. is a distinguished clinical research facility with specialized expertise in neurological pain disorders, particularly focusing on migraine research and neuropathic pain conditions. The center has established itself as a leading site for evaluating innovative therapeutic approaches across multiple phases of clinical development.
- Comprehensive migraine studies including chronic, episodic, and menstrual migraine prevention and acute treatment
- Diabetic peripheral neuropathy and neuropathic pain research with novel analgesic compounds
- Advanced drug delivery systems including oral medications, injectables, and aerosol formulations
- Long-term safety evaluations and open-label extension studies
The center demonstrates particular strength in conducting migraine clinical trials, with extensive experience evaluating CGRP antagonists like atogepant, monoclonal antibodies, and botulinum toxin formulations such as Dysport® for both chronic and episodic migraine prevention. Additionally, Dado Medical has expertise in complex pain studies, including diabetic peripheral neuropathic pain trials utilizing innovative approaches such as medical cannabis aerosol delivery systems. The facility's capabilities span from early-phase dose-finding studies to large-scale Phase 3 trials with extended follow-up periods, demonstrating comprehensive research infrastructure and patient recruitment capabilities in the neurology and pain management therapeutic areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AbbVie Deutschland GmbH & Co. KG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AbbVie Deutschland GmbH & Co. KG4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dado Medical s.r.o.
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Atogepant in Acute Migraine Treatment: A Randomized, Double-Blind, Placebo-Controlled Study | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Apr 2024 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atogepant | 3 | Unknown | 2021-08-16 | 2025-03-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.